Connecting Global Priorities Biodiversity and Human Health

Pruden, A. (2013). Balancing water sustainability and public
health goals in the face of growing concerns about antibiotic
resistance. Environmental Science & Technology, 48(1), 5–14.
Radimersky, T., Frolkova, P., Janoszowska, D., Dolejska, M.,
Svec, P., Roubalova, E., ... & Literak, I. (2010). Antibiotic
resistance in faecal bacteria (Escherichia coli, Enterococcus
spp.) in feral pigeons. Journal of Applied Microbiology, 109(5),
1687–1695.
Redshaw, C. H., Stahl-Timmins, W. M., Fleming, L. E.,
Davidson, I., & Depledge, M. H. (2013). Potential changes
in disease patterns and pharmaceutical use in response to
climate change. Journal of Toxicology and Environmental Health,
Part B, 16(5), 285–320.
Rico A, Van den Brink PJ, (2014). Probabilistic risk assessment
of veterinary medicines applied to four major aquaculture
species produced in Asia. Science of the Total Environment.
468–469; 630–641.
Santos, L. H., Araújo, A. N., Fachini, A., Pena, A.,
Delerue-Matos, C., & Montenegro, M. C. B. S. M. (2010).
Ecotoxicological aspects related to the presence of
pharmaceuticals in the aquatic environment. Journal of
Hazardous Materials, 175(1–3), 45–95.
Schroeder, K., Thompson, T., Frith, K., & Pencheon, D.
(2013) A Vision for Sustainable Healthcare. (pp 72–91).
In: Thompson, T., Frith, K., & Pencheon, D. Sustainable
Healthcare. John Wiley & Sons.
Smith J. S. (2014). Health Impact of Pharmaceuticals in the
Environment and in Drinking Water: Potential for Human
and Environmental Risk. (pp. 91–102) In: Goldstein, W., (ed)
Pharmaceutical Accumulation in the Environment: Prevention,
Control, Health Effects, and Economic Impact, CRC Press, Baton
Rouge. 262pp.
Stackelberg, P. E., Furlong, E. T., Meyer, M. T., Zaugg, S. D.,
Henderson, A. K., & Reissman, D. B. (2004). Persistence of
pharmaceutical compounds and other organic wastewater
contaminants in a conventional drinking-water-treatment
plant. Science of the Total Environment, 329(1), 99–113.
Taylor, D. (2010). Ecopharmacostewardship – a
pharmaceutical industry perspective. In: Kümmerer and
Hempel (eds) Green and Sustainable Pharmacy (pp. 105–126).
Springer Berlin Heidelberg. 313pp
Taylor, N. G., Verner-Jeffreys, D. W., & Baker-Austin, C.
(2011). Aquatic systems: maintaining, mixing and mobilising
antimicrobial resistance?. Trends in Ecology & Evolution, 26(6),
278–284.
Vatovec, C., Senier, L., & Bell, M. (2013). An ecological
perspective on medical care: environmental, occupational, and
public health impacts of medical supply and pharmaceutical
chains. EcoHealth, 10(3), 257–267.
Vickery JA, Tallowin JR, Feber RE., Asteraki EJ, Atkinson PW,
Fuller RJ, Brown VK, (2001). The management of lowland
neutral grasslands in Britain: effects of agricultural practices
on birds and their food resources. Journal of Applied Ecology,
38: 647–664.
Weinberger J, Klaper R, (2014). Environmental concentrations
of the selective serotonin reuptake inhibitor fluoxetine impact
specific behaviors involved in reproduction, feeding and
predator avoidance in the fish Pimephales promelas (fathead
minnow). Aquatic Toxicology 151; 77–83.
Wellington, E. M., Boxall, A. B., Cross, P., Feil, E. J., Gaze,
W. H., Hawkey, P. M., ... & Williams, A. P. (2013). The role
of the natural environment in the emergence of antibiotic
resistance in Gram-negative bacteria. The Lancet Infectious
Diseases, 13(2), 155–165.
Wickramsinghe LP, Harris S, Jones G, Vaughan Jennings N,
(2004). Abundance and Species Richness of Nocturnal Insects
on Organic and Conventional Farms: Effects of Agricultural
Intensification on Bat Foraging. Conservation Biology, 18:
1283–1292.
World Health Organisation (WHO) (2011). Pharmaceuticals
in Drinking Water. WHO, Geneva.
WHO (2012) The Evolving Threat of Antimicrobial Resistance –
Options for Action. WHO, Geneva, 120pp
WHO (2014). Antimicrobial Resistance: Global Report on
Surveillance. WHO, Geneva. 256pp
Chapter 11
Alves, R. R., & Alves, H. N. (2011). The faunal drugstore:
Animal-based remedies used in traditional medicines in Latin
America. Journal of ethnobiology and ethnomedicine, 7(9):
1–43.
Alves, R.R.N. and Rosa, I.M.L. (2007). Biodiversity, traditional
medicine and public health: Where do they meet? Journal of
Ethnobiology and Ethnomedicine, 3: 14–22.
Alves, R.R.N. and Rosa, I.M.L. (2005). Why study the use
of animal products in traditional medicines? Journal of
Ethnobiology and Ethnomedicine, 1, 5–9.
Anonymous, (2008). A renaissance in primary health care. The
Lancet, 372: 9642. Available online at: http://www.thelancet.
com/journals/lancet/article/PIIS0140–6736(08)61369–0/
fulltext#
Balabanova, D., Mills, A., Conteh, L., Akkazieva, B.,
Banteyerga, H., Dash, U,Gilson, L., Hammer, A., Ibraimova,
A., Islam, Z., Kidanu, A., Koehlmoos, T P., Limwattananon,
S., Muraleedharan, VR. Murzalieva G., Palafox B.,
Panichkriangkrai, W., Patcharanrumol, W., Penn-Kekana
L., Powell-Jackson, T. Tangcharoensathien, V and McKee,
M (2013). Good health at low cost 25 years on: lessons
for the future of health systems strengthening. The Lancet,
381(9883), 2118–2133.
Balick, M. J., & Cox, P. A. (1996). Plants, people, and culture:
the science of ethnobotany. Scientific American Library.
Battiste, M. 2010. Indigenous knowledge and indigenous
peoples’ education. In: S.M. Subramanian and B.
Pisupati, (Eds.) (2010). Traditional Knowledge in Policy and
Practice:Approaches to Development and Human Well-being.
Tokyo: UNU Press, pp.31–51.
322 Connecting Global Priorities: Biodiversity and Human Health